Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Midkine: an emerging target of drug development for treatment of multiple diseases.
Disclosing a misdiagnosis of multiple sclerosis: do no harm?
Oral BG-12 (dimethyl fumarate) for relapsing-remitting multiple sclerosis: a review of DEFINE and CONFIRM Evaluation of: Gold R, Kappos L, Arnold D, et al. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med 2012;
Founder mutations in NDRG1 and HK1 genes are common causes of inherited neuropathies among Roma/Gypsies in Slovakia.
A survey of advice on driving in neurological conditions amongst neurologists and neurosurgeons.
Childhood Guillain-Barré syndrome subtypes in northern India.
Paraoxonase 1 in neurological disorders.
Balo Concentric Sclerosis in Children: A Case Series.
A sphenoid sinus mucocele simulating as retro bulbar optic neuritis.
Peripartum depression in parents with multiple sclerosis and psychiatric disorders in children.
Dimethyl fumarate in the management of multiple sclerosis: appropriate patient selection and special considerations.
Modern communication technology skills of patients with multiple sclerosis.
Immunohistochemical detection of sphingosine-1-phosphate receptor 1 and 5 in human multiple sclerosis lesions.
Relation between Pro-inflammatory Cytokines and Acetylcholine Levels in Relapsing-Remitting Multiple Sclerosis Patients.
Immunoadsorption in steroid-refractory multiple sclerosis.
High prevalence of vitamin D deficiency and cancer in Saudi Arabian populations: Can we hypothesize a link?
Optimizing JC and BK polyomavirus IgG testing for seroepidemiology and patient counseling.
The Lin28/let-7 axis is critical for myelination in the peripheral nervous system.
The brain as 'immunoprecipitator' of serum autoantibodies against NMDAR1.
Evolution of myelin ultrastructure and the major structural myelin proteins.
Multiple sclerosis-Indian perspective.
Therapeutic Intervention in Multiple Sclerosis with Alpha B-Crystallin: A Randomized Controlled Phase IIa Trial.
Quantitation of Teriflunomide in Human Serum/Plasma Across a 40,000-Fold Concentration Range by LC/MS/MS.
(1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis.
An open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditions.
Pages
« first
‹ previous
…
618
619
620
621
622
623
624
625
626
…
next ›
last »